August 10, 2020

Predicting Efficacy of ImmunoDx Using AI

BY Dr. Keith J. Kaplan

Artificial Intelligence, Business, Clinical Laboratories, Data Management, Device Manufacturers, Digital Pathology News, File format, Informatics, Laboratory Management & Operations, New Digital Imaging Technologies, Pathology News, Vendor products, Whole slide

A reliable and intelligent digital pathology solution needs image analysis toolset that helps pathologists to trustfully and accurately assess whole tissue slide images.

OptraSCAN’s completely automated PD-L1 image analysis evaluates and generates scores for both, regions of interest and whole slide analysis with minimal human intervention.

Request More Information

Source: OptraScan

Lumea Announces Availability of Cxbladder™ Tests on BxLink™ Platform

LEHI, UT, UNITED STATES, December 5, 2024 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions, is excited to announce that Cxbladder™, a suite of non-invasive genomic urine tests optimized for the risk stratification and...

Predicting Efficacy of ImmunoDx Using AI

next article

Lumea Announces Availability of Cxbladder™ Tests on BxLink™ Platform

platinum partners

gold partners

Silver Partners

Media Partners